Scott B. Ullem, CVP, Chief Financial Officer at Edwards Lifesciences Corp (EW), sold 23,906 shares at $74.40 ($1.8M) on 2025-05-09, disclosed to the SEC on 2025-05-09.
Scheduled sale ($1.8M) by CVP, Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $74.92 | 1,406 | $105K | 5.9% |
| 2 | $74.40 | 11,250 | $837K | 47.0% |
| 3 | $74.40 | 11,250 | $837K | 47.0% |
| Total | $74.43 avg | 23,906 | $1.8M | 100% |
| Filing → |
| EW | SELL | 2025-12-09 | $650K | — | Filing → |
| EW | SELL | 2025-11-10 | $2.2M | — | Filing → |
| EW | SELL | 2025-03-26 | $1.6M | — | Filing → |